Consistent with this hypothesis, FMT from LTS patients into mice harboring implanted KPC tumors showed enhanced immune infiltration and reduced tumor growth in a CD8+ T cell-dependent manner compared with FMT from STS and healthy control donors (Riquelme et al, 2019). The gene discussed is CD8A; the disease is neoplasm.